Serum prostatic acid phosphatase and prostate-specific antigen in screening, diagnosis, staging, and treatment of prostate cancer

G. L. Andriole

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Serum prostatic acid phosphatase and prostate specific antigen are potentially very useful clinical tools for the screening, diagnosis, staging and management of men with prostate cancer. However, optimal implementation of these tests requires a thorough understanding of their strengths and limitations in guiding management of patients with known, or suspected, prostate cancer.

Original languageEnglish
Pages (from-to)366-376
Number of pages11
JournalProblems in Urology
Volume4
Issue number3
StatePublished - Jan 1 1990

Fingerprint

Dive into the research topics of 'Serum prostatic acid phosphatase and prostate-specific antigen in screening, diagnosis, staging, and treatment of prostate cancer'. Together they form a unique fingerprint.

Cite this